Skip to main content Accessibility help
×
Home

Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus Infection Among Patients With End-Stage Renal Disease

  • Leonard B. Johnson (a1) (a2), Anilrudh A. Venugopal (a1), Joan Pawlak (a1) and Louis D. Saravolatz (a1) (a2)

Extract

Objective.

To evaluate the frequency of infections due to community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) strains among our patients with end-stage renal disease.

Design.

Prospective observational clinical and laboratory study of patients in 2005. Molecular features of isolates recovered from these patients were compared with those of isolates recovered in 2000 from patients with end-stage renal disease.

Setting.

A 600-bed urban academic medical center.

Patients.

Thirty-two patients with end-stage renal disease and MRSA infection at the time of hospitalization from 2005 were evaluated. For comparison, laboratory analysis was performed for 17 MRSA isolates recovered from patients with end-stage renal disease in 2000.

Results.

The patients from 2005 were more likely than the patients from 2000 to have infection with strains that carried the staphylococcal cassette chromosome (SCC) mec type IV complex (50% vs 11.8%; relative risk, 4.25 [95% confidence interval, 1.17-25.98]; P = .012) and the Panton-Valentine leukocidin toxin genes (25% vs 0%; P = .038). Eight patients from 2005 were infected with a strain that is identical to MRSA clone USA300 in terms of molecular type and presence of SCCmec type IV and Panton-Valentine leukocidin genes. Among the patients from 2005, those infected with SCCmec type IV strains (ie, CA-MRSA strains) and those infected with SCCmec type II strains (ie, healthcare-associated MRSA [HA-MRSA] strains) were similar with respect to demographic characteristics, risk factors, and outcomes.

Conclusions.

We documented an increased proportion of infections with CA-MRSA strains, including clone USA300, among our population of patients undergoing dialysis. Patients infected with CA-MRSA strains and HA-MRSA strains were similar with respect to presenting illness and outcomes.

Copyright

Corresponding author

19251 MackAvenue, Suite 340, Grosse Pointe Woods, Michigan 48236, (leonard.johnson@stjohn.org)

References

Hide All
1. Colley, EW, McNicol, MW, Bracken, PM. Methicillin-resistant staphylococci in a general hospital. Lancet 1965; 1:595597.
2. Barrett, FF, McGehee, RF Jr, Finland, M. Methicillin resistant Staphylococcus aureus at Boston City Hospital. N Engl J Med 1968; 27:441448.
3. Saravolatz, LD, Markowitz, N, Arking, L, Pohlod, D, Fisher, E. Methicillin-resistant Staphylococcus aureus: epidemiologic observations during a community-acquired outbreak. Ann Intern Med 1982; 96:1116.
4. Saravolatz, LD, Pohlod, DJ, Arking, LM. Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks. Ann Intern Med 1982; 97:325329.
5. Herold, BC, Immergluck, LC, Maranan, MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279:593597.
6. Center for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus—Minnesota and North Dakota, 1997-1999. JAMA 1999; 282:11231125.
7. Nimmo, GR, Schooneveldt, J, O'Kane, G, McCall, B, Vickery, A. Community acquisition of gentamicin-sensitive methicillin-resistant Staphylococcus aureus in southeast Queensland, Australia. J Clin Microbiol 2000;38:39263931.
8. Salmenlinna, S, Lyytikainen, O, Vuopio-Varkila, J. Community-acquired methicillin-resistant Staphylococcus aureus, Finland. Emerg Infect Dis 2002; 8:602607.
9. Centers for Disease Control and Prevention. Community-associated methicillin-resistant Staphylococcus aureus infections in Pacific Islanders—Hawaii, 2001-2003. MMWR Morb Mortal Wkly Rep 2004; 53:767770.
10. Daum, RS, Ito, T, Hiramatsu, K, et al. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis 2002; 186:13441347.
11. Dufour, P, Gillet, Y, Bes, M, et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002; 35:819824.
12. Naimi, TS, LeDell, KH, Como-Sabetti, K, et al. Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003; 290:29762984.
13. D'Agata, EMC. Antimicrobial-resistant, gram-positive bacteria among patients undergoing chronic hemodialysis. Clin Infect Dis 2002; 35:12121218.
14. Salzer, W. Antimicrobial-resistant gram-positive bacteria in PD peritonitis and the newer antibiotics used to treat them. Perit Dial Int 2005; 25:313319.
15. Reed, SD, Friedman, JY, Engemann, JJ, et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2005; 26:175183.
16. Saiman, L, O'Keefe, M, Graham, PL, et al. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis 2003; 37:13131319.
17. Bratu, S, Eramo, A, Kopec, R, et al. Community-associated methicillin-resistant Staphylococcus aureus in hospital nursery and maternity units. Emerg Infect Dis 2005; 11:808813.
18. Kourbatova, EV, Halvosa, JS, King, MD, Ray, SM, White, N, Blumberg, HM. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health-care associated infections among patients with prosthetic joint infections. Am J Infect Control 2005; 33:385391.
19. NCCLS. Performance Standards for Antimicrobial Susceptibility Testing: Fourteenth International Supplement. Wayne, PA: NCCLS; 2004.
20. Matushek, MG, Bonten, MJM, Hayden, MK. Rapid preparation of bacterial DNA for pulsed-field gel electrophoresis. J Clin Microbiol 1996; 34:25982600.
21. Tenover, FC, Arbeit, RD, Goering, RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:22332239.
22. McDougal, LK, Steward, CD, Killgore, GE, Chaitram, JM, McAllister, SK, Tenover, FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003; 41:51135120.
23. Oliveira, DC, de Lencastre, H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus . Antimicrob Agents Chemother 2002; 46:21552161.
24. Okuma, K, Iwakawa, K, Turnidge, JD, et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002; 40:42894294.
25. Mongkolrattanothai, K, Boyle, S, Kahana, MD, Daum, RS. Severe Staphylococcus aureus infections caused by clonally related community-acquired methicillin-susceptible and methicillin-resistant isolates. Clin Infect Dis 2003; 37:10501058.
26. King, MD, Humphrey, BJ, Wang, YF, Kourbatova, EV, Ray, SM, Blumberg, HM. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA300 clone as the predominant cause of skin and soft tissue infections. Ann Intern Med 2006; 144:309317.
27. Johnson, LB, Saeed, S, Pawlak, J, Manzor, O, Saravolatz, LD. Clinical and laboratory features of community-associated methicillin-resistant Staphylococcus aureus: is it really new? Infect Control Hosp Epidemiol 2006; 27:133138.
28. Enayet, I, Nazeri, A, Johnson, LB, Riederer, K, Pawlak, J, Saravolatz, LD. Community-associated methicillin-resistant Staphylococcus aureus (CAMRSA) causing chronic pneumonia. Clin Infect Dis 2006; 42:e57e60.
29. Chapman, ALN, Greig, JM, Innes, JA. MRSA in the community. N Engl J Med 2005; 353:530532.
30. Miller, LG, Perdreau-Remington, F, Rieg, G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352:14451453.
31. Lesens, O, Hansmann, Y, Brannigan, E, et al. Healthcare-associated Staphylococcus aureus bacteremia and the risk for methicillin resistance: is the Centers for Disease Control and Prevention definition for community-acquired bacteremia still appropriate? Infect Control Hosp Epidemiol 2005; 26:204209.
32. Seybold, U, Kourbatova, EV, Johnson, JG, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of healthcare-associated blood stream infections. Clin Infect Dis 2006; 42:647656.
33. Nouwen, JL, Fieren, WJA, Snijders, S, Verbrugh, HA, Van Belkum, A. Persistent (not intermittent) nasal carriage of Staphylococcus aureus is the determinant of CPD-related infections. Kidney International 2005; 67:10841092.
34. Fowler, VG Jr, Kong, LK, Corey, RG, et al. Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients. J Infect Dis 1999; 179:11571161.

Related content

Powered by UNSILO

Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus Infection Among Patients With End-Stage Renal Disease

  • Leonard B. Johnson (a1) (a2), Anilrudh A. Venugopal (a1), Joan Pawlak (a1) and Louis D. Saravolatz (a1) (a2)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.